1,456
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial

ORCID Icon, , , , , , , , , , , , , , , , & show all
Article: 2327442 | Received 06 Nov 2023, Accepted 04 Mar 2024, Published online: 13 Mar 2024

References

  • Bilinski J, Robak K, Peric Z, Marchel H, Karakulska-Prystupiuk E, Halaburda K, Rusicka P, Swoboda-Kopec E, Wroblewska M, Wiktor-Jedrzejczak W et al. Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of allogeneic hematopoietic stem cell transplantation: a retrospective, single-center study. Biol Blood Marrow Transplant. 2016;22(6):1087–13. doi:10.1016/j.bbmt.2016.02.009.
  • Sadowska-Klasa A, Piekarska A, Prejzner W, Bieniaszewska M, Hellmann A. Colonization with multidrug-resistant bacteria increases the risk of complications and a fatal outcome after allogeneic hematopoietic cell transplantation. Ann Hematol. 2018;97(3):509–517. doi:10.1007/s00277-017-3205-5.
  • Scheich S, Lindner S, Koenig R, Reinheimer C, Wichelhaus TA, Hogardt M, Besier S, Kempf VAJ, Kessel J, Martin H. et al. Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia. Cancer. 2018;124(2):286–296. doi:10.1002/cncr.31045.
  • Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, Viale A, Socci ND, van den Brink MRM, Kamboj M, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010;120(12):4332–4341. doi:10.1172/JCI43918.
  • Ghani R, Mullish BH, McDonald JAK, Ghazy A, Williams HRT, Brannigan ET, Mookerjee S, Satta G, Gilchrist M, Duncan N, et al. Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms. Clin Infect Dis. 2021;72(8):1444–1447. doi:10.1093/cid/ciaa948.
  • Innes AJ, Mullish BH, Ghani R, Szydlo RM, Apperley JF, Olavarria E, Palanicawandar R, Kanfer EJ, Milojkovic D, McDonald JAK, et al. Fecal microbiota transplant mitigates adverse outcomes seen in patients colonized with multidrug-resistant organisms undergoing allogeneic hematopoietic cell transplantation. Front Cell Infect Microbiol. 2021;11:684659. doi:10.3389/fcimb.2021.684659.
  • Battipaglia G, Malard F, Rubio MT, Ruggeri A, Mamez AC, Brissot E, Giannotti F, Dulery R, Joly AC, Baylatry MT, et al. Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria. Haematologica. 2019;104(8):1682–1688. doi:10.3324/haematol.2018.198549.
  • Bilinski J, Grzesiowski P, Sorensen N, Madry K, Muszynski J, Robak K, Wroblewska M, Dzieciatkowski T, Dulny G, Dwilewicz-Trojaczek J, et al. Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria: results of a prospective, single-center study. Clin Infect Dis. 2017;65(3):364–370. doi:10.1093/cid/cix252.
  • Matzaras R, Nikopoulou A, Protonotariou E, Christaki E. Gut microbiota modulation and prevention of dysbiosis as an alternative approach to antimicrobial resistance: a narrative review. Yale J Biol Med. 2022;95(4):479–494. doi:10.1101/gr.096651.109.
  • Rashidi A, Ebadi M, Rehman TU, Elhusseini H, Kazadi D, Halaweish H, Khan MH, Hoeschen A, Cao Q, Luo X, et al. Randomized double-blind phase II trial of fecal microbiota transplantation versus placebo in allogeneic hematopoietic cell transplantation and AML. J Clin Oncol. 2023;41(34):5306–5319. doi:10.1200/JCO.22.02366.
  • Staley C, Hamilton MJ, Vaughn BP, Graiziger CT, Newman KM, Kabage AJ, Sadowsky MJ, Khoruts A. Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study. Am J Gastroenterol. 2017;112(6):940–947. doi:10.1038/ajg.2017.6.
  • Vaughn BP, Fischer M, Kelly CR, Allegretti JR, Graiziger C, Thomas J, McClure E, Kabage AJ, Khoruts A. Effectiveness and safety of colonic and capsule fecal microbiota transplantation for recurrent clostridioides difficile infection. Clin Gastroenterol Hepatol. 2023;21(5):1330–7.e2. doi:10.1016/j.cgh.2022.09.008.
  • Sandberg KD, Ishii S, LaPara TM. A microfluidic quantitative polymerase chain reaction method for the Simultaneous Analysis of Dozens of Antibiotic Resistance and heavy metal Resistance genes. Environ Sci Technol Lett. 2018;5(1):20–25. doi:10.1021/acs.estlett.7b00552.
  • Zhang A-N, Gaston JM, Dai CL, Zhao S, Poyet M, Groussin M, Yin X, Li L-G, van Loosdrecht MCM, Topp E. et al. An omics-based framework for assessing the health risk of antimicrobial resistance genes. Nat Commun. 2021;12(1):4765. doi:10.1038/s41467-021-25096-3.
  • Ishii S, Segawa T, Okabe S. Simultaneous quantification of multiple food- and waterborne pathogens by use of microfluidic quantitative PCR. Appl Environ Microb. 2013;79(9):2891–2898. doi:10.1128/AEM.00205-13.
  • Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol. 1995;57(1):289–300. doi:10.1111/j.2517-6161.1995.tb02031.x.
  • Muratore E, Leardini D, Baccelli F, Venturelli F, Prete A, Masetti R. Nutritional modulation of the gut microbiome in allogeneic hematopoietic stem cell transplantation recipients. Front Nutr. 2022;9:993668. doi:10.3389/fnut.2022.993668.
  • Shouval R, Waters NR, Gomes ALC, Zuanelli Brambilla C, Fei T, Devlin SM, Nguyen CL, Markey KA, Dai A, Slingerland JB, et al. Conditioning regimens are associated with distinct patterns of microbiota injury in allogeneic hematopoietic cell transplantation. Clin Cancer Res. 2023;29(1):165–173. doi:10.1158/1078-0432.CCR-22-1254.
  • Barton MD. Antibiotic use in animal feed and its impact on human healt. Nutr Res Rev. 2000;13(2):279–299. doi:10.1079/095442200108729106.
  • Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579–587. doi:10.1016/S0140-6736(05)17907-0.
  • Sommer MOA, Church GM, Dantas G. The human microbiome harbors a diverse reservoir of antibiotic resistance genes. Virulence. 2010;1(4):299–303. doi:10.4161/viru.1.4.12010.
  • Wellington EMH, Boxall AB, Cross P, Feil EJ, Gaze WH, Hawkey PM, Johnson-Rollings AS, Jones DL, Lee NM, Otten W. et al. The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria. Lancet Infect Dis. 2013;13(2):155–165. doi:10.1016/S1473-3099(12)70317-1.
  • Rampelli S, Schnorr SL, Consolandi C, Turroni S, Severgnini M, Peano C, Brigidi P, Crittenden AN, Henry AG, Candela M. Metagenome sequencing of the hadza hunter-gatherer gut microbiota. Curr Biol. 2015;25(13):1682–1693. doi:10.1016/j.cub.2015.04.055.
  • Fitzpatrick D, Walsh F, Smalla K. Antibiotic resistance genes across a wide variety of metagenomes. FEMS Microbiol Ecol. 2016;92(2):fiv168. doi:10.1093/femsec/fiv168.
  • Lee K, Kim D-W, Lee D-H, Kim Y-S, Bu J-H, Cha J-H, Thawng CN, Hwang E-M, Seong HJ, Sul WJ, et al. Mobile resistome of human gut and pathogen drives anthropogenic bloom of antibiotic resistance. Microbiome. 2020;8(1):2. doi:10.1186/s40168-019-0774-7.
  • Enne VI, Livermore DM, Stephens P, Hall LM. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet. 2001;357(9265):1325–1328. doi:10.1016/S0140-6736(00)04519-0.
  • Rashidi A, Ebadi M, Rehman TU, Elhusseini H, Kazadi D, Halaweish H, Khan MH, Hoeschen A, Cao Q, Luo X. et al. Potential of fecal microbiota transplantation to prevent acute graft-versus-host disease. Clin Cancer Res. 2023;29(23):4920–4929. doi:10.1158/1078-0432.CCR-23-2369.
  • Jalanka J, Mattila E, Jouhten H, Hartman J, de Vos WM, Arkkila P, Satokari R. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection. BMC Med. 2016;14(1):155. doi:10.1186/s12916-016-0698-z.
  • Leung V, Vincent C, Edens TJ, Miller M, Manges AR. Antimicrobial resistance gene acquisition and depletion following fecal microbiota transplantation for recurrent clostridium difficile infection. Clin Infect Dis. 2018;66(3):456–457. doi:10.1093/cid/cix821.
  • Millan B, Park H, Hotte N, Mathieu O, Burguiere P, Tompkins TA, Kao D, Madsen KL. Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection. Clin Infect Dis. 2016;62(12):1479–1486. doi:10.1093/cid/ciw185.